S. Balakrishna Pai - Concepedia

Author

S. Balakrishna Pai

The Wallace H. Coulter Department of Biomedical Engineering ORCID

Also Known As

S B Pai, S Balakrishna Pai, S Pai, S. B. PAI, S. B. Pai, S. Balakrishna Pai, S. Pai, S.B. Pai, S.Balakrishna Pai, SB Pai

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

The Wallace H. Coulter Department of Biomedical Engineering Georgia Institute of Technology Emory University University of Georgia Yale University

About

S. Balakrishna Pai is an author at The Wallace H. Coulter Department of Biomedical Engineering specializing in medicine, pharmacology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	1.1K
2	Engineering	8	8	416
3	Biochemistry	6	6	287
4	Biomedical Engineering	6	6	370
5	Natural Sciences	4	4	147

S. Balakrishna Pai

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus C. K. CHU, Tianwei Ma, Kirupa Shanmuganathan, Antimicrobial Agents and Chemotherapy Vitro PotencyNovel Antiviral AgentImmunologyPharmacotherapyAnti-epstein-barr Virus Agent	1995	229
Synthesis and Biological Evaluation of 2',3'-Dideoxy-L-pyrimidine Nucleosides as Potential Antiviral Agents against Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV) Tai‐Shun Lin, Mei‐Zhen Luo, Mao‐Chin Liu, Journal of Medicinal Chemistry	1994	155
Guiding intracortical brain tumour cells to an extracortical cytotoxic hydrogel using aligned polymeric nanofibres Anjana Jain, Martha I. Betancur, Gaurangkumar Patel, Nature Materials Tissue EngineeringHydrogelsNeuro-oncologyExtracortical Cytotoxic HydrogelEngineering	2014	149
Structure−Activity Relationships of 1-(2-Deoxy-2-fluoro-β-<scp>l</scp>-arabino- furanosyl)pyrimidine Nucleosides as Anti-Hepatitis B Virus Agents Tianwei Ma, S. Balakrishna Pai, Yong Zhu, Journal of Medicinal Chemistry	1996	141
Inhibition of hepatitis B virus by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyl uracil S. Balakrishna Pai, S H Liu, Y.‐L. Zhu, Antimicrobial Agents and Chemotherapy Isolated Hbv ParticlesBiochemistryViral HepatitisDrug DiscoveryMedicine	1996	141
Nanocarrier-Mediated Inhibition of Macrophage Migration Inhibitory Factor Attenuates Secondary Injury after Spinal Cord Injury Tarun Saxena, Kristin H. Loomis, S. Balakrishna Pai, ACS Nano EngineeringImmunologyCell DeathBiomedical EngineeringNeuroinflammation	2015	94
Antiviral activity of 2′,3′-dideoxy-β-L-5-fluorocytidine (β-L-FddC) and 2′,3′-dideoxy-β-L-cytidine (β-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro Tai‐Shun Lin, Luo Mei-Zhen, Mao‐Chin Liu, Biochemical Pharmacology Antiviral ActivityMedicineImmunologyAntiviral ResponseHepatitis	1994	93
Enhanced therapeutic neovascularization by CD31-expressing cells and embryonic stem cell-derived endothelial cells engineered with chitosan hydrogel containing VEGF-releasing microtubes Sangho Lee, Chandra M. Valmikinathan, Jaemin Byun, Biomaterials Tissue EngineeringRegenerative MedicineCell-based Drug DeliveryAngiogenesisEngineering	2015	80
Development of sulforaphane-encapsulated microspheres for cancer epigenetic therapy S. Balakrishna Pai, Syed A. A. Rizvi, Malcolm J. D’Souza International Journal of Pharmaceutics NanomedicineMicro-encapsulationNano-drug DeliveryTumor TargetingMatrix Biology	2009	75
Therapeutic efficacy of microtube-embedded chondroitinase ABC in a canine clinical model of spinal cord injury Hilary Z. Hu, Nicolas Granger, S. Balakrishna Pai, Brain	2018	70

Page 1